Randomised phase III trial of radical chemo/radiotherapy vs radiotherapy alone in the definitive management of localised muscle invasive TCC of the urinary bladder
Primary Sponsor
Urological Society of Australasia
Collaborating Groups
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
67
Trial Chairperson
Dr Kumar Gogna, QRI Mater Centre, QLD
Trial Contact
Kumar Gogna
Clinical Trial Registration
Related Post
13 November, 2024
Trek4TROG team rise to Blue Mountains challenge
November 2024: Congratulations to the Trek4TROG team for successfully
24 October, 2024
Promising new results from RAIDER trial published
24 October 2024: Newly published findings from the TROG
